Navigation Links
Epigenetic and MicroRNA Biomarkers 2013 Market Report
Date:8/8/2013

DUBLIN, August 8, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/tx3prw/epigenetic_and) have announced the addition of the "Epigenetic and MicroRNA Biomarkers 2013 Market Report" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

This market report represents the most up-to-date analysis of the Epigenetic and MicroRNA Biomarkers spaces together with research market data [qualitative and quantitative analysis] characterizing the epigenetics and microRNA research fields.

The epigenetic and microRNA biomarkers fields are co-evolving and have reached a critical point wherein enough signatures have been identified across various different disease classes, most notably in cancer, that some of these signatures/expression patterns can be validated and deployed for use in the clinic. However, these biomarker fields are evolving in parallel with the research marketplace, and therefore the authors have in this market report characterized the research markets for both these fields so as to present a comprehensive analysis that en bloc provides a complete picture of this expanding marketplace.

Key Topics Covered

Epigenetics Research Market Analysis

- Primary Market Survey to Characterize Research Market Trends based on Data Collected from Researchers
- Breakout of Epigenetics Research Activity based on Epigenetic Modifications Studied
- Segmentation of Epigenetics Research Activity based on Disease Classes Studied
- Epigenetics Research Activity in Cancer--Quantitative Segmentation
- Reagent Kits and Products in the Epigenetics Research Field [Details of Products from the Vendors in this Space are Presented and Analyzed]

Epigenetics Biomarkers

- En masse Analysis of All Epigenetics-focused Publications and Trends from these Data with respect to Potential Epigenetics Biomarkers
- Description of Epigenetic Biomarkers Identified to Date in Various Cancer Classes [Nature of Epigenetic Signature, Potential Role in Prognostics and Diagnostics]

MicroRNA Research Market Analysis

- Primary Market Survey Data Presents a Complete Picture of the microRNA Research Field based on End-User/Researcher Practices
- Methodologies and Market Breakout for Expression Profiling
- Quantitative Breakout of the microRNA Research Market Across the Research Workflow
- Product Vendors and their Quantitative Penetrance in the microRNA Research Markets

MicroRNA Biomarkers Analysis

- Expression Patterns/Signatures of microRNAs in Different Disease States
- Prognostic/Diagnostic Potential of microRNA Expression Patterns
- microRNAs in Biological Fluids as Circulating Biomarkers: List and Significance

Cancer Biomarker Classes

- Traditional Cancer Biomarkers
- Oncogenes
- Tumor-Suppressor Genes

Companion Diagnostics (CDx)

- Up-to-date List of CDx on the Marketplace
- Partnerships in the CDx Space 

For more information visit http://www.researchandmarkets.com/research/tx3prw/epigenetic_and

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biotechnology


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Epigenetics Holds Key to Healthier Future
2. NIH Awards New England Biolabs a Phase II SBIR Grant for the Research and Development of Novel Enzymes for Epigenetic Studies
3. GeneTex Launches New Antibody Against Phosphorylated Histone H3 for Epigenetics Research
4. Transcreener Assays Highlighted for Challenging Microbial, Cancer and Epigenetic Drug Targets at SLAS 2013
5. Epigenetics: Changing the Way We Think about DNA
6. GeneTex Introduces New Mouse Monoclonal Antibody Against the Ten-Eleven Translocation 1 (TET1) Protein for DNA Methylation/Epigenetics Research
7. RiboMed and Austrian Institute of Technology Partner on Epigenetic Tests for Early Lung Cancer Detection, Sub-typing and Drug Response
8. BellBrook Labs and Tecan Offer Webinar on Screening Epigenetic Targets
9. OvaGene Oncology Collaborates With Moffitt Cancer Center to Develop and Commercialize microRNAs Associated With Chemotherapeutic Drug Response
10. ResearchMoz: MicroRNA Market Trends 2011
11. Dr. Victor Ambros and Dr. Gary Ruvkun Win 2012 Dr. Paul Janssen Award for Biomedical Research for Discovery of MicroRNAs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... 29, 2016 , ... Amendia, Inc., a leading designer, developer, ... the completion of a significant transaction and partnership that positions Amendia for accelerated ... Kohlberg & Company, L.L.C. (“Kohlberg”), a leading private equity firm specializing in ...
(Date:4/29/2016)... , ... April 29, 2016 , ... Intelligent Implant Systems ... the FDA via 510(k) for sale in the United States. These components expand ... thoraco-lumbar fusions. With one-level sales beginning in October of 2015, the company has ...
(Date:4/28/2016)... ... April 28, 2016 , ... Connecticut Innovations ... companies, today announced the launch of VentureClash , a $5 million global ... , “VentureClash looks to attract the best early-stage companies here in Connecticut, around ...
(Date:4/27/2016)... ... ... Cambridge Semantics, the leading provider of Smart Data analytic and data management ... The Silicon Review’s “20 Fastest Growing Big Data Companies of 2016.” , “From ... end users facing some of the most complex data challenges in the industry,” said ...
Breaking Biology Technology:
(Date:3/31/2016)... , March 31, 2016   ... ("LegacyXChange" or the "Company") LegacyXChange is excited ... of its soon to be launched online site for ... https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential shareholders a ... DNA technology to an industry that is notorious for ...
(Date:3/22/2016)... , PROVO and ... -- Newborn Screening Ontario (NSO), which operates the highest ... for molecular testing, and Tute Genomics and UNIConnect, leaders ... technology respectively, today announced the launch of a project ... sequencing (NGS) testing panel. NSO has ...
(Date:3/15/2016)... 2016 Yissum Research Development Company of ... of the Hebrew University, announced today the formation of ... of various human biological indicators. Neteera Technologies has completed ... private investors. ... of electromagnetic emissions from sweat ducts, enables reliable and ...
Breaking Biology News(10 mins):